Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment.

IF 1.7 3区 医学 Q4 ANDROLOGY Translational andrology and urology Pub Date : 2024-09-30 Epub Date: 2024-09-26 DOI:10.21037/tau-24-235
Yu Imai, Fumihiko Urabe, Ibuki Sadakane, Takahiro Oguchi, Kosuke Iwatani, Masaya Murakami, Kojiro Tashiro, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Shunsuke Tsuzuki, Kenta Miki, Takahiro Kimura
{"title":"Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment.","authors":"Yu Imai, Fumihiko Urabe, Ibuki Sadakane, Takahiro Oguchi, Kosuke Iwatani, Masaya Murakami, Kojiro Tashiro, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Shunsuke Tsuzuki, Kenta Miki, Takahiro Kimura","doi":"10.21037/tau-24-235","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiparametric magnetic resonance imaging (mpMRI) is increasingly used for the early detection of clinically significant prostate cancer (csPCa). However, the achievement of accurate detection rates, particularly for transition zone (TZ) lesions, remains challenging. We investigated the relationship between apparent diffusion coefficient (ADC) values in Prostate Imaging Reporting and Data System (PI-RADS) 3-5 lesions and csPCa within the TZ.</p><p><strong>Methods: </strong>We retrospectively evaluated TZ lesions in patients who underwent 3.0 Tesla MRI followed by MRI-targeted/transrectal ultrasound fusion biopsies (MRI-FBx). Fusion biopsies were performed for potentially cancerous lesions, defined as lesions with PI-RADS scores 3-5. We analyzed 196 lesions for which fusion biopsies were performed.</p><p><strong>Results: </strong>The overall prostate cancer (PCa) detection rate was 53.6% (105/196); csPCa constituted 33.7% (66/196) of cases. The minimum ADC value was significantly lower for patients with csPCa (484.9±112.3 µm<sup>2</sup>/s) than for patients with benign histology or non-csPCa (P<0.001). Older age, higher initial prostate-specific antigen level, larger region of interest, and minimum and mean ADC values were associated with the presence of csPCa. Multivariate analysis indicated that only the minimum ADC value was an independent predictor of csPCa. Using a cutoff minimum ADC value <561 µm<sup>2</sup>/s to detect csPCa in TZ lesions increased the detection rate to 57.4% (54/94).</p><p><strong>Conclusions: </strong>The minimum ADC value provides substantial additional information regarding the presence of csPCa in the TZ, potentially improving the detection rates for lesions rated as PI-RADS 3-5 and informing the need for follow-up biopsies in areas that are initially cancer-free.</p>","PeriodicalId":23270,"journal":{"name":"Translational andrology and urology","volume":"13 9","pages":"2027-2035"},"PeriodicalIF":1.7000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491234/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational andrology and urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tau-24-235","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multiparametric magnetic resonance imaging (mpMRI) is increasingly used for the early detection of clinically significant prostate cancer (csPCa). However, the achievement of accurate detection rates, particularly for transition zone (TZ) lesions, remains challenging. We investigated the relationship between apparent diffusion coefficient (ADC) values in Prostate Imaging Reporting and Data System (PI-RADS) 3-5 lesions and csPCa within the TZ.

Methods: We retrospectively evaluated TZ lesions in patients who underwent 3.0 Tesla MRI followed by MRI-targeted/transrectal ultrasound fusion biopsies (MRI-FBx). Fusion biopsies were performed for potentially cancerous lesions, defined as lesions with PI-RADS scores 3-5. We analyzed 196 lesions for which fusion biopsies were performed.

Results: The overall prostate cancer (PCa) detection rate was 53.6% (105/196); csPCa constituted 33.7% (66/196) of cases. The minimum ADC value was significantly lower for patients with csPCa (484.9±112.3 µm2/s) than for patients with benign histology or non-csPCa (P<0.001). Older age, higher initial prostate-specific antigen level, larger region of interest, and minimum and mean ADC values were associated with the presence of csPCa. Multivariate analysis indicated that only the minimum ADC value was an independent predictor of csPCa. Using a cutoff minimum ADC value <561 µm2/s to detect csPCa in TZ lesions increased the detection rate to 57.4% (54/94).

Conclusions: The minimum ADC value provides substantial additional information regarding the presence of csPCa in the TZ, potentially improving the detection rates for lesions rated as PI-RADS 3-5 and informing the need for follow-up biopsies in areas that are initially cancer-free.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
优化过渡区前列腺癌检测:前列腺磁共振成像评估中表观扩散系数值与前列腺成像报告和数据系统(PI-RADS)评估的分析。
背景:多参数磁共振成像(mpMRI)越来越多地用于早期检测有临床意义的前列腺癌(csPCa)。然而,实现准确的检测率,尤其是过渡区(TZ)病变的检测率,仍然具有挑战性。我们研究了前列腺成像报告和数据系统(PI-RADS)3-5 病变的表观扩散系数(ADC)值与 TZ 内 csPCa 之间的关系:我们对接受3.0特斯拉核磁共振成像(3.0 Tesla MRI)和核磁共振成像靶向/经直肠超声融合活检(MRI-FBx)的患者的TZ病变进行了回顾性评估。融合活检针对的是可能癌变的病灶,即 PI-RADS 评分为 3-5 分的病灶。我们对进行了融合活检的196个病灶进行了分析:结果:前列腺癌(PCa)总检出率为 53.6%(105/196);csPCa 占 33.7%(66/196)。csPCa患者的最小ADC值(484.9±112.3 µm2/s)明显低于良性组织学或非csPCa患者(P2/s检测TZ病变中的csPCa可将检测率提高到57.4%(54/94)):最小 ADC 值为 TZ 中是否存在 csPCa 提供了大量额外信息,有可能提高被评为 PI-RADS 3-5 级病变的检出率,并告知是否需要对最初无癌的区域进行后续活检。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.10
自引率
5.00%
发文量
80
期刊介绍: ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.
期刊最新文献
Construction of a survival model for predicting biochemical recurrence of prostate cancer based on propionate metabolism-related genes. From symptomatic relief to restorative medicine: a comprehensive review of diabetic erectile dysfunction. Evaluation of collagen membrane grafting in managing Peyronie's disease and penile curvature: a pilot study. Global research landscape and technological breakthroughs in post-prostatectomy urinary incontinence management: a bibliometric review and visualized study. Development and validation of an MRI radiomics-based model for predicting progression risk in prostate cancer after endocrine therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1